Page last updated: 2024-08-23

du-21220 and Lung Diseases

du-21220 has been researched along with Lung Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Higuchi, T; Inayama, Y; Kawakami, K; Mandai, M; Mizuno, K; Okuda, A; Takeuchi, M1
Ward, MJ; White, JP1

Reviews

1 review(s) available for du-21220 and Lung Diseases

ArticleYear
Drug-induced adverse pulmonary reactions.
    Adverse drug reactions and acute poisoning reviews, 1985,Winter, Volume: 4, Issue:4

    Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Hydrochlorothiazide; Hypertension, Pulmonary; Lung Diseases; Lupus Erythematosus, Systemic; Lymphatic Diseases; Mediastinum; Methotrexate; Nitrofurantoin; Penicillamine; Pleural Effusion; Pulmonary Edema; Pulmonary Eosinophilia; Pulmonary Fibrosis; Ritodrine

1985

Other Studies

1 other study(ies) available for du-21220 and Lung Diseases

ArticleYear
Long-term vs short-term tocolysis with ritodrine hydrochloride: Propensity score-matched analysis.
    European journal of obstetrics, gynecology, and reproductive biology, 2023, Volume: 282

    Topics: Female; Humans; Infant, Newborn; Lung Diseases; Obstetric Labor, Premature; Pregnancy; Premature Birth; Propensity Score; Retrospective Studies; Ritodrine; Tocolysis; Tocolytic Agents

2023